ZY
ZHENGYE BIOTECHNOLOGY HLDG L
ZYBT·G989MS101·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic
ZYBT (ZHENGYE BIOTECHNOLOGY HLDG L) is held by 6 institutional investors as of Q2 2026. Largest holders: XTX Topco Ltd ($33,086), GEODE CAPITAL MANAGEMENT, LLC ($19,681), UBS Group AG ($5,410). Net institutional sentiment: Mixed.
6
Holders
$59,438
Total Value
50% (4)
Consensus
2 buying - 2 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders none · Activists none · Congress none
No recent insider, activist, or congressional trades for ZYBT.
Top Holders
Checking access…
ZYZYBTZHENGYE BIOTECHNOLOGY HLDG L
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer